September 30, 2016 1:02 AM ET

Pharmaceuticals

Company Overview of Kalypsys, Inc.

Key Executives for Kalypsys, Inc.

NameBoard RelationshipsTitleAge
Audrey Schellinger No RelationshipsDirector of Human Resources--
Rodney Turner No RelationshipsExecutive Director of World Wide Systems Sales--

Kalypsys, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Shehan Bharatha Dissanayake Ph.D. 55 RelationshipsTavistock Life Sciences--
Vijay K. Lathi 42 RelationshipsNew Leaf Venture Partners, L.L.C.44
Suzy Goldberger 7 RelationshipsKalypsys, Inc.--
Christopher Fuglesang Ph.D., J.D. 11 RelationshipsMVA Investors, LLC47
Isy Goldwasser 12 RelationshipsThync, Inc.46
View All Board Members

Kalypsys, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Shehan Bharatha Dissanayake55 Relationships1 Executives
Compensation Committee Vijay K. Lathi42 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
403.2K
Bonus
511.2K
Total Short Term Compensation
591.4K
Total Value of Options
14.2M
Compensation as of Fiscal Year
Kalypsys, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Morepen Laboratories Ltd Announces Departure of Archana S. Bhargava as Director
September 28, 2016 12:33 PM ET
Assembly Biosciences Announces Executive Appointments
September 28, 2016 11:00 AM ET
Cornelia (Cori) Bargmann to Step Down as Non-Executive Director of AstraZeneca, Effective October 1, 2016
September 28, 2016 6:00 AM ET
Abattis Bioceuticals Corp. Appoints Shuang Xie as Newest Science and Technology Advisor
September 27, 2016 8:20 PM ET
Kitov Pharmaceuticals Holdings Ltd. Announces Resignation of Moran Sherf Blau from the Board of Directors and all Board Committees
September 27, 2016 1:29 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kalypsys, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.